Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”
Saved in:
| Main Authors: | Cesar Daniel Alonso-Bello, María del Carmen Jiménez-Martínez, María Eugenia Vargas-Camaño, Sagrario Hierro-Orozco, Mario Alberto Ynga-Durand, Laura Berrón-Ruiz, Julio César Alcántara-Montiel, Leopoldo Santos-Argumedo, Diana Andrea Herrera-Sánchez, Fernando Lozano-Patiño, María Isabel Castrejón-Vázquez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Immunology |
| Online Access: | http://dx.doi.org/10.1155/2021/2361360 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome
by: Cesar Daniel Alonso-Bello, et al.
Published: (2019-01-01) -
Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
by: Divya R, et al.
Published: (2020-01-01) -
Advances in omalizumab treatment for IgE-mediated food allergies
by: Siqi WANG, et al.
Published: (2025-08-01) -
Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study
by: Christo Tsilifis, et al.
Published: (2025-08-01) -
Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation
by: Chad J. Cooper, et al.
Published: (2014-01-01)